For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230509:nRSI8291Ya&default-theme=true
RNS Number : 8291Y Agronomics Limited 09 May 2023
9 May 2023
Agronomics Limited (https://agronomics.im/)
("Agronomics" or the "Company")
Directors' Dealings
Agronomics, the leading listed company focused on the field of cellular
agriculture, is pleased to confirm that Jim Mellon, Executive Director, a
PDMR, purchased an additional 392,000 ordinary shares in the Company
("Ordinary Shares") at an average price of 11.56 pence per share on 5th May
2023.
Following these transactions, Jim Mellon is interested in a total of
154,553,366 Ordinary Shares, representing 15.56% of the issued capital, of
which 139,448,641 are held by Galloway Limited and 12,722,764 are held by
Shellbay Investments Limited, companies which are both indirectly wholly owned
by Jim Mellon, and 2,381,961 Ordinary Shares are held directly by Mr Mellon.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET
ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS
SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.
About Agronomics
Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of over 20 companies in this rapidly advancing sector. It seeks to
secure minority stakes in companies owning technologies with defensible
intellectual property that offer new ways of producing food and materials with
a focus on products historically derived from animals. These technologies are
driving a major disruption in agriculture, offering solutions to improve
sustainability, as well as addressing human health, animal welfare and
environmental damage. This disruption will decouple supply chains from the
environment and animals and be fundamental to feeding the world's expanding
population. A full list of Agronomics' portfolio companies is available at
https://agronomics.im/ (https://agronomics.im/) .
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists' claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃.
AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food Institute's
estimate that a US $1.8 trillion investment will be required in order to
produce just 10% of the world's protein using this technology, means that we
are on the cusp of a multi-decade flow of capital to build out manufacturing
facilities. Funding in the field of cellular agriculture is accelerating,
however, still, less than US$ 5 billion has been invested worldwide since the
industry's inception in 2016.
For further information please contact:
Agronomics Beaumont Canaccord Genuity Limited Cenkos Peterhouse Capital
Limited Cornish Limited Securities Plc Limited
The Company Nomad Joint Broker Joint Broker Joint Broker
Richard Reed Roland Cornish Andrew Potts Giles Balleny Lucy Williams
Denham Eke James Biddle Harry Rees Michael Johnson Charles Goodfellow
Alex Aylen (Head of Equities)
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 523 8000 +44 (0) 207 397 8900 +44 (0) 207 469 0936
info@agronomics.im
1 Details of the person discharging managerial responsibilities /
person closely associated
a) Name Jim Mellon
2 Reason for notification
a) Position / status Executive Director
b) Initial notification Initial
/Amendment
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Agronomics Limited
b) LEI 21380029M8MPIEQ3TL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument 392,000 Ordinary shares of £0.000001 each in Agronomics Limited
Identification code
ISIN IM00B6QH1J21
Nature of the transaction Market purchase of Ordinary Shares
c) Price(s) and volumes(s)
Price(s) Volumes(s)
11.56 pence 392,000
d) Aggregated information n/a
e) Date of the transaction 4 & 5 May 2023
f) Place of the transaction On market
d)
Aggregated information
n/a
e)
Date of the transaction
4 & 5 May 2023
f)
Place of the transaction
On market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUPUMUAUPWGWB